Stock News

EPS for Medtronic plc (MDT) Expected At $1.14

Medtronic plc (NYSE:MDT) LogoInvestors sentiment decreased to 0.98 in 2018 Q2. Its down 0.10, from 1.08 in 2018Q1. It fall, as 49 investors sold Medtronic plc shares while 436 reduced holdings. 99 funds opened positions while 374 raised stakes. 1.03 billion shares or 0.70% less from 1.04 billion shares in 2018Q1 were reported.
Spectrum Mngmt Inc has 0% invested in Medtronic plc (NYSE:MDT) for 146 shares. Strategic Fin Services reported 0.76% in Medtronic plc (NYSE:MDT). Bollard Grp Limited Liability has 0.01% invested in Medtronic plc (NYSE:MDT). New York-based Silvercrest Asset Management Group has invested 0.08% in Medtronic plc (NYSE:MDT). Prelude Cap Mgmt Limited Liability Co, New York-based fund reported 3,650 shares. Roberts Glore And Company Inc Il holds 0.35% or 6,743 shares in its portfolio. Blue Chip Partners invested in 1,927 shares. The California-based Fdx has invested 0.14% in Medtronic plc (NYSE:MDT). 4,300 are held by Perritt Capital Mgmt. Fund Evaluation Gru Inc Limited Company has invested 0.55% in Medtronic plc (NYSE:MDT). Northwest Investment Counselors Ltd holds 0.63% or 18,150 shares. Anchor Capital Advsr Lc owns 0.84% invested in Medtronic plc (NYSE:MDT) for 266,903 shares. New York-based Meyer Handelman has invested 1.16% in Medtronic plc (NYSE:MDT). Bryn Mawr accumulated 13,093 shares. Jupiter Asset Management reported 0.86% in Medtronic plc (NYSE:MDT).

Analysts expect Medtronic plc (NYSE:MDT) to report $1.14 EPS on November, 20.They anticipate $0.07 EPS change or 6.54 % from last quarter’s $1.07 EPS. MDT’s profit would be $1.54B giving it 20.69 P/E if the $1.14 EPS is correct. After having $1.17 EPS previously, Medtronic plc’s analysts see -2.56 % EPS growth. The stock decreased 0.40% or $0.38 during the last trading session, reaching $94.36. About 4.31M shares traded. Medtronic plc (NYSE:MDT) has risen 16.95% since November 10, 2017 and is uptrending. It has outperformed by 1.33% the S&P500.

Medtronic plc (NYSE:MDT) Ratings Coverage

Among 12 analysts covering Medtronic (NYSE:MDT), 7 have Buy rating, 0 Sell and 5 Hold. Therefore 58% are positive. Medtronic had 17 analyst reports since May 24, 2018 according to SRatingsIntel. Argus Research maintained the shares of MDT in report on Monday, October 8 with “Buy” rating. The rating was maintained by BMO Capital Markets with “Outperform” on Wednesday, August 22. The firm has “Equal-Weight” rating by Morgan Stanley given on Friday, May 25. The stock has “Strong Buy” rating by Needham on Monday, August 13. The firm earned “Buy” rating on Wednesday, August 22 by Bank of America. The firm has “Equal-Weight” rating given on Wednesday, August 22 by Morgan Stanley. Needham maintained Medtronic plc (NYSE:MDT) on Thursday, May 24 with “Buy” rating. Argus Research maintained the stock with “Buy” rating in Monday, August 27 report. Stifel Nicolaus maintained the stock with “Hold” rating in Wednesday, August 22 report. The stock of Medtronic plc (NYSE:MDT) earned “Buy” rating by Bank of America on Wednesday, June 6.

Medtronic plc manufactures and sells device medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company has market cap of $127.43 billion. The company's Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; diagnostics and monitoring devices; mechanical circulatory support, TYRX, and AF products; and remote monitoring and patient-centered software. It has a 40.69 P/E ratio. It also provides transcatheter heart valves, percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular products, and products to treat superficial and deep venous diseases.

More news for Medtronic plc (NYSE:MDT) were recently published by: Globenewswire.com, which released: “Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2019” on November 09, 2018. Globenewswire.com‘s article titled: “Medtronic Delivers Significant Progress on Global Corporate Citizenship Efforts” and published on November 08, 2018 is yet another important article.

Medtronic plc (NYSE:MDT) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *

*